# InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

> **NCT01026285** · — · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 1085 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Risperidone Long-Acting injectable or oral antipsychotics

## Key facts

- **NCT ID:** NCT01026285
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 1085 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026285, "InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01026285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*